Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma

E-ISSN： 1097-0142|121|22|4007-4015

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.22, 2015-11, pp. : 4007-4015

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor‐risk metastatic renal cell carcinoma

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3435-3443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2612-2617

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 443-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 326-332

Karger

Access to resources Recommend Favorite

Acral melanoma foot lesions. Part 2: clinical presentation, diagnosis, and management

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 43, Iss. 2, 2018-03 ,pp. : 117-123

John Wiley & Sons Inc

Access to resources Recommend Favorite